Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

This study has been completed.
Sponsor:
Collaborator:
Canadian Foundation for AIDS Research (CANFAR)
Information provided by (Responsible Party):
Johane Allard, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00152893
First received: September 8, 2005
Last updated: July 17, 2013
Last verified: July 2013